(S (S (NP (NN Transfer) (NN learning)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ effective) (PP (IN in) (NP (NP (JJ many) (NNS applications)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (NN training) (NNS data)) (PP (IN for) (NP (DT the) (NN target) (NN problem)))) (VP (VBP are) (ADJP (JJ limited))))))))))))))) (CC but) (S (NP (NP (NNS data)) (PP (IN for) (NP (DT a) (ADJP (JJ related) (PRN (-LRB- -LRB-) (NP (NN source)) (-RRB- -RRB-))) (NN problem)))) (VP (VBP are) (ADJP (JJ abundant)))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP apply) (NP (NN transfer) (NN learning)) (PP (IN to) (NP (NP (DT the) (NN prediction)) (PP (IN of) (NP (JJ anti-cancer) (NN drug) (NN response)))))) (. .))
(S (NP (NP (JJ Previous) (NN transfer)) (VP (VBG learning) (NP (NP (NNS studies)) (PP (IN for) (NP (NN drug) (NN response) (NN prediction)))))) (VP (VBD focused) (PP (IN on) (NP (NP (NN building) (NNS models)) (SBAR (WHNP (WDT that)) (S (VP (VBP predict) (NP (NP (DT the) (NN response)) (PP (IN of) (NP (NN tumor) (NNS cells)))) (PP (IN to) (NP (DT a) (JJ specific) (NN drug) (NN treatment))))))))) (. .))
(S (NP (PRP We)) (VP (VBP target) (NP (NP (DT the) (JJR more) (JJ challenging) (NN task)) (PP (IN of) (S (VP (VBG building) (NP (NP (JJ general) (NN prediction) (NNS models)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB make) (NP (NNS predictions)) (PP (IN for) (NP (NP (DT both) (JJ new) (NN tumor) (NNS cells)) (CC and) (NP (JJ new) (NNS drugs)))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP apply) (NP (DT the) (JJ classic) (NN transfer)) (S (VP (VBG learning) (NP (NP (NN framework)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ trains) (NP (DT a) (NN prediction) (NN model)) (PP (IN on) (NP (DT the) (NN source) (NN dataset)))) (CC and) (VP (VBZ refines) (NP (PRP it)) (PP (IN on) (NP (DT the) (NN target) (NN dataset)))) (, ,) (CC and) (VP (VBZ extends) (NP (DT the) (NN framework)) (PP (IN through) (NP (NN ensemble))))))))))) (. .))
(S (NP (DT The) (NN ensemble) (NML (NN transfer) (NN learning)) (NN pipeline)) (VP (VBZ is) (VP (VBN implemented) (S (VP (VBG using) (NP (NP (NNP LightGBM)) (CC and) (NP (CD two) (JJ deep) (NML (NML (JJ neural) (NN network)) (-LRB- -LRB-) (NML (NN DNN)) (-RRB- -RRB-)) (NNS models))) (PP (IN with) (NP (JJ different) (NNS architectures))))))) (. .))
(S (ADVP (RB Uniquely)) (, ,) (NP (PRP we)) (VP (VBP investigate) (NP (PRP$ its) (NN power)) (PP (IN for) (NP (NP (CD three) (NN application) (NNS settings)) (PP (VBG including) (NP (NP (NN drug) (NN repurposing)) (, ,) (NP (NN precision) (NN oncology)) (, ,) (CC and) (NP (JJ new) (NN drug) (NN development)))))) (, ,) (PP (IN through) (NP (NP (JJ different) (NNS data)) (NP (NP (NN partition) (NNS schemes)) (PP (IN in) (NP (NN cross-validation))))))) (. .))
(S (NP (PRP We)) (VP (VBP test) (NP (DT the) (VBN proposed) (NN ensemble) (NN transfer) (NN learning)) (PP (IN on) (NP (NP (NN benchmark) (ADJP (FW in) (FW vitro)) (NN drug) (NN screening) (NNS datasets)) (, ,) (VP (VBG taking) (NP (NP (NP (CD one) (NN dataset)) (PP (IN as) (NP (DT the) (NN source) (NN domain)))) (CC and) (NP (NP (DT another) (NN dataset)) (PP (IN as) (NP (DT the) (NN target) (NN domain))))))))) (. .))
(S (NP (DT The) (NN analysis)) (VP (VBZ results) (SBAR (S (VP (VBP demonstrate) (NP (NP (DT the) (NN benefit)) (PP (IN of) (S (VP (VBG applying) (NP (NP (NN ensemble) (NN transfer) (NN learning)) (PP (IN for) (S (VP (VBG predicting) (NP (NP (JJ anti-cancer) (NN drug) (NN response)) (PP (IN in) (NP (DT all) (CD three) (NNS applications)))) (PP (IN with) (NP (DT both) (NML (NNP LightGBM) (CC and) (NNP DNN)) (NNS models))))))))))))))) (. .))
(S (PP (VBN Compared) (PP (IN between) (NP (DT the) (JJ different) (NN prediction) (NNS models)))) (, ,) (NP (NP (DT a) (NN DNN) (NN model)) (PP (IN with) (NP (NP (CD two) (NNS subnetworks)) (PP (IN for) (NP (NP (DT the) (NNS inputs)) (PP (IN of) (NP (NML (NML (NN tumor) (NNS features)) (CC and) (NML (NN drug))) (NNS features)))))))) (ADVP (RB separately)) (VP (VBZ outperforms) (NP (NP (NP (NNP LightGBM)) (CC and) (NP (DT the) (JJ other) (NNP DNN) (NN model))) (SBAR (WHNP (WDT that)) (S (VP (VBZ concatenates) (NP (NP (NML (NML (NN tumor) (NNS features)) (CC and) (NML (NN drug))) (NNS features)) (PP (IN for) (NP (NN input)))) (PP (IN in) (NP (NP (DT the) (NN drug) (NN repurposing)) (CC and) (NP (NN precision) (NN oncology) (NNS applications))))))))) (. .))
(S (PP (IN In) (NP (NP (DT the) (ADJP (JJR more) (JJ challenging)) (NN application)) (PP (IN of) (NP (JJ new) (NN drug) (NN development))))) (, ,) (NP (NNP LightGBM)) (VP (VBZ performs) (ADJP (ADJP (JJR better)) (PP (IN than) (NP (DT the) (JJ other) (CD two) (NN DNN) (NNS models))))) (. .))
